02616.HK
CStone Pharmaceuticals
HKSE · Healthcare · Biotechnology · CN
HKD 5.34
−0.84%Margins
Gross margin
55.5%
EBITDA margin
-81.3%
EBIT margin
-91.8%
Net margin
-98.4%
FCF margin
-13.3%
-32.2%
Return on equity
-20.2%
Return on assets
-23.5%
Return on invested capital
0.25x
Asset turnover
-HKD 65.5M
Cash from operations
HKD 1.31
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026